Skip to main content

Advertisement

Peer Review reports

From: Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

Original Submission
26 Apr 2018 Submitted Original manuscript
5 Jun 2018 Reviewed Reviewer Report - Eisuke Arai
26 Jul 2018 Reviewed Reviewer Report - Tomohito Hagi
16 Aug 2018 Author responded Author comments - Loïc Lebellec
Resubmission - Version 2
16 Aug 2018 Submitted Manuscript version 2
28 Aug 2018 Reviewed Reviewer Report - Tomohito Hagi
4 Sep 2018 Reviewed Reviewer Report - Eisuke Arai
11 Sep 2018 Author responded Author comments - Loïc Lebellec
Resubmission - Version 3
11 Sep 2018 Submitted Manuscript version 3
Publishing
18 Sep 2018 Editorially accepted
11 Oct 2018 Article published 10.1186/s12885-018-4828-1

You can find further information about peer review here.

Back to article page